Broker says sell: IAG (ASX:IAG) share price slumps 3.5%

Here's what might be weighing on the IAG share price today.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Monday is proving to be rough for the Insurance Australia Group Ltd (ASX: IAG) share price. Its struggle comes after a top broker downgraded the company's stock.

UBS dropped its price target for IAG shares to $4.20 over the weekend, slapping them with a sell rating.

At the time of writing, the IAG share price is $4.25, 3.52% lower than its previous close of $4.40.

For context, the S&P/ASX 200 Index (ASX: XJO) is recording a 0.6% gain today.

Let's take a closer look at what the broker has to say about the insurance provider's shares.

Keyboard button with the word sell on it, symbolising the time being right to sell ASX stocks.

Image source: Getty Images

IAG share price tumbles amid broker downgrade

The IAG share price is suffering amid a flurry of broker downgrades.

As The Motley Fool Australia reported yesterday, the company's shares were recently downgraded to 'underweight' by Morgan Stanley and plastered with a $3.75 price target.

Now, UBS has followed suit. According to reporting by The Australian, the broker told clients that it's concerned by a lawsuit facing an IAG subsidiary and the company's growth prospects. UBS analysts were quoted as saying:

The preeminent NRMA franchise is being sued by the corporate regulator for overcharging. The commercial lines business is addressing a cost problem and undergoing remediation work.

The group's volume outlook is weak after divesting most of its growth options in recent years. The net positive impacts presented by COVID over the past two years are now reversing as supply-side constraints drive a spike in claims.

Indeed, IAG announced that the Australian Securities and Investments Commission (ASIC) launched civil proceedings against its subsidiary in October.

The watchdog alleges the company increased premiums for some NRMA insurance customers before applying loyalty and 'no claim' discounts.

The analysts also reportedly stated:

We understand there is substantial claims "catch-up" now coming through as states open up and building and motor supply bottlenecks tighten.

This will not only utilise the lockdown savings of [the first quarter of financial year 2022], but likely require further home and motor repricing into [2022].

This comes at the same time as ASIC's impending lawsuit into overcharging, which implies that Direct Insurance Australia has over-earned by ~3% of annual margin since [the second half of financial year 2018].

Today's tumble included, the IAG share price is 10% lower than it was at the start of 2021. It has also fallen 3.9% over the last 30 days.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns and has recommended Insurance Australia Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Bell Potter says this ASX 200 stock can rise 38% and pay a 6% dividend yield

Major upside and a generous dividend yield could be on offer with this name.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A woman holds her finger to the side of her face and looks upwards as she thinks about something.
Broker Notes

4 ASX shares at 52-week lows: Buy, hold, or sell?

Here's what the experts think.

Read more »

A female athlete in green spandex leaps from one cliff edge to another representing 3 ASX shares that are destined to rise and be great
Broker Notes

Up 57% since February, why Telix shares could keep leaping higher in 2026

A leading analyst believes investors are undervaluing Telix shares. But why?

Read more »

A happy young woman in a red t-shirt hold up two delicious burritos.
Broker Notes

Guzman Y Gomez shares just sank to new all-time lows. Time to buy?

A leading analyst provides his outlook for the battered Guzman Y Gomez share price.

Read more »